Ginsenoside Rg2 showed a property of alleviating the myocardial fibrosis and improving the impairment of cardiac function by regulating the TGF-β1/Smad signalling pathway after myocardial ischaemia. This evidence concerns the gene TGFB1 and Myocardial fibrosis.